TARDBP and amyotrophic lateral sclerosis: Data thus indicated that NCL is able to trigger beneficial effects toward both ALS- and FTLD-related TDP-43 cytotoxicity, pointing to the determination of the molecular mechanism(s) at the basis of such ability.